Friday, December 4, 2020

COVID-19 vaccine: Zydus Cadila gets DGCI nod for phase 3 clinical trials of Pegylated Interferon Alpha-2

Drug firm Zydus Cadila on Friday said it has received the approval from the Drugs Controller General of India (DCGI) to start phase 3 clinical trials with its biological therapy PegiHep in COVID-19 patients.

from IndiaTV India: Google News Feed https://ift.tt/3oket9y
via
at
Labels:

No comments:

Post a Comment

Please do not enter spam link in the comment box. Suggestions are invited for improvement.

Subscribe to: Post Comments (Atom)

Republic Day 2024: French band, marching contingent and Rafale jets participate in parade | WATCH

Republic Day 2024 : As India's 75th Republic Day Parade kicked off in the national capital, a 30-member band contingent and a marching c...